Syntax Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Syntax Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$221K	Buy	3,808 +258	+7%	+$15.8K	0.19%	154
2023 Q2	$227K	Sell	3,550 -98	-3%	-$6.57K	0.18%	167
2023 Q1	$253K	Buy	3,648 +576	+19%	+$40.6K	0.19%	145
2022 Q4	$221K	Sell	3,072 -590	-16%	-$44.5K	0.18%	166
2022 Q3	$260K	Buy	3,662 +454	+14%	+$32.9K	0.22%	97
2022 Q2	$247K	Sell	3,208 -127	-4%	-$9.67K	0.21%	129
2022 Q1	$244K	Sell	3,335 -1,281	-28%	-$86K	0.2%	153
2021 Q4	$288K	Buy	+4,616	New	+$271K	0.21%	105

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Syntax Advisors's BMY Position: Q3 2023 in Review

Syntax Advisors increased its Bristol-Myers Squibb (BMY) stake by 7.3% in Q3 2023, buying an estimated $15.8K and bringing the position to 3,808 shares worth $221K. The position accounts for 0.19% of the portfolio, ranked #154.

Syntax Advisors first reported a position in BMY in Q4 2021 and has held it in 8 quarters since. The position peaked at $288K in Q4 2021. 2,387 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

Syntax Advisors held 3,808 shares of Bristol-Myers Squibb worth $221K as of Q3 2023.
Syntax Advisors bought 258 Bristol-Myers Squibb shares in Q3 2023, an estimated $15.8K.
Bristol-Myers Squibb made up 0.19% of Syntax Advisors's portfolio in Q3 2023, its #154 holding.
Syntax Advisors first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 8 quarters since.
Syntax Advisors's Bristol-Myers Squibb position peaked at $288K in Q4 2021.
2,387 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Syntax Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.